DIVALCOTE 250 mg, gastro-resistant tablet 30 tablets, CIP 3400930212547
Active ingredients: Valproic acid, DIVALPROATE DE SODIUM
Commercialized according to BDPMANSM noticeDispensing in France: Prescription only
Gastro-resistant tablet30 tablets, CIP 3400930212547orale
Supply resumed
Package details
Original BDPM fields are shown in French.
- Official name
- DIVALCOTE 250 mg, comprimé gastro-résistant
- Pharmaceutical form
- comprimé gastro-résistant(e)
- Route of administration
- orale
- Presentation description
- plaquette(s) aluminium de 30 comprimé(s)
- Marketing authorisation holder
- VIATRIS SANTE
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 13 Dec 2021
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Requires special monitoring during treatment
- Initial prescription by a specialist
- Prescribed by specialists only
- Enhanced ANSM monitoring
- Yes
BDPM identifiers
CIS
63413610CIP73021254CIP133400930212547Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ACIDE VALPROÏQUEcomprimé | 250 mg · un comprimé | FT |
| DIVALPROATE DE SODIUMcomprimé | 269,059 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.